Research Output per year
The GVL and Immunotherapy research group investigates the immune system of patients with CML and post stem cell transplant. My role as the Research officer within our small group involves a range of tasks. The main task is to process samples collected from the patients, store and catalogue the details for use in future research projects. The other tasks involve performing cell based assays and data entry to assist the Post-doctoral researcher and PhD student within the group.
Bachelor's Degree, University of South Australia
Research Scientist13 Oct 2014 → …
Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemiaRoss, D. M., Pagani, I., Irani, Y., Clarson, J., Gray, T., Dang, Y., McLean, J., Saunders, V., Carne, L., Reynolds, J., Ritchie, D. S., White, D., Branford, S., Hughes, T. & Yong, A., 1 Aug 2019, In : British Journal of Haematology. 186, 3, p. e56-e60
Research output: Contribution to journal › Letter
CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressorsHughes, A., Clarson, J., Tang, C., Vidovic, L., White, D. L., Hughes, T. P. & Yong, A. S. M., 2 Mar 2017, In : Blood. 129, 9, p. 1166-1176 11 p.
Research output: Contribution to journal › Article
Comment on “KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study”Hughes, A., Clarson, J., Gargett, T., Yu, W., Brown, M. P., Lopez, A. F., Hughes, T. P. & Yong, A. S. M., 1 Apr 2017, In : Leukemia Research. 55, p. 55-57 3 p.
Research output: Contribution to journal › Editorial